In e-Science, where vast data collections are processed in scientific workflows, new risks and challenges are emerging. Those challenges are changing the e-Science paradigm, mainly regarding Digital Preservation and scientific workflows. To address specific concerns with Data Management in these scenarios, the concept of Data Management Plan was established, serving as a tool for enabling Digital Preservation in e-Science research projects. We claim Risk Management can be jointly used with Data Management Plan, so new risks and challenges can be easily tackled. Therefore, we propose an analysis process for e-Science projects using Data Management Plan and ISO 31000 in order to create a Risk Management Plan that can complement the Data Management Plan. The motivation, requirements and validation of this proposal is the project MetaGen-FRAME, focused in Metagenomics.
Introduction
E-Science typically represents increasingly global collaborations of people and resources (Hey et al, 2003) , using large scale infrastructures to process vast data sets, where Data Management (DM) and Digital Preservation (DP) concerns are addressed to mitigate the emerging risks to digital objects (Paul et al, 2003) .
Within the DM and DP concerns, the concept of Data Management Plan (DMP) is used to represent the set of rules and good practices, according to the objectives of specific stakeholders (usually, a funding organization), a project must follow regarding DM (Fernandes et al, 2012) . From another viewpoint, a DMP intends to "protect" digital objects against several threats that exist in typical e-Science workflows. As the mitigation of risks is the main goal of Risk Management (RM), an opportunity arises for understanding how RM can be used to enrich the DMP concept.
The motivation and validation of our proposal was the MetaGen-FRAME project (Coimbra, 2012) , which we expect we will be able to generalize for the field of Bioengineering (heterogeneous area, comprising biology, medicine, bioinformatics, etc.) . In this sense, we understand MetaGen-FRAME to be an e-Science and Metagenomic project, focused on sequence analysis and genome annotation.
This paper is structured as follows: First, we outline the principles of e-Science, scientific workflows, DM and DMP. Second, we introduce the concepts of DP, RM and Risk Management Plan (RMP). Third, we describe an analytical process for creating an RMP. Fourth, we present the previous process' validation based on the MetaGen-FRAME project. Finally, we present the major conclusions and some remarks of future work.
Data Management in E-Science
E-Science involves global collaboration and large data sets supported by an infrastructure (Jankowski, 2007) . It is based on scientific workflows, allowing scientists to execute, reconfigure and rerun their analysis in a verifiable way (Braga et al, 2007) , typically involving many steps and vast data sets (Deelman et al, 2008) .
DM is an integral part of e-Science. It allows researchers to produce higher quality data, increase the exposure of their research and protect data from being lost or misused (Fernandes et al, 2012) . The scientific community has increasingly perceived concerns about DM, namely data's provenance, sharing, access and archival (Fernandes et al, 2012) . As a result of these concerns, research funders have been increasingly requesting the inclusion of a DMP as part of the project proposals. A typical DMP describes how data will be created, stored and shared, with two purposes (Fernandes et al, 2012) : (i) guide researchers to reuse data; (ii) record the project's DM decisions.
Digital Preservation as a Risk Management Approach
DP aims to keep digital objects accessible over long periods of time (Lipkis et al, 2005) . For that, digital objects must be what they claim to be, implying trustworthiness and authenticity. Information provenance and traceability must be assured. DP environments might require scalability to face technology's evolution achieved through replacement of technological components, thus implying heterogeneity (Barateiro et al, 2010) . (Barateiro et al, 2010) . A risk can be triggered by a positive event (opportunity), or negative event (threat) (Barateiro, 2012) .
Standards, methods and tools for RM vary with the market sector, type of business or organizational activities (Ramirez, 2008) . There are standards that focus on defining the generic terminology, process, principles, methods and techniques, as well as specific domain standards (Ferreira et al, 2013a) . ISO 31000 proposes a reference process to execute RM properly (ISO/FDIS 31000, 2009) ( Figure 1 ). The process proposes that firstly the context, strategic objectives and risk criteria of RM must be defined (Barateiro et al, 2010) . The next step is Risk Assessment, which is composed of three distinct phases: risk identification, which generates the list of risks (Barateiro et al, 2010) ; risk analysis, to consider the impacts and probabilities determining the risk level; and risk evaluation, to determine what risks need treatment or can be only controlled. The next step is risk treatment, where controls are designated to risks. Communication and review takes place throughout all previous stages.
An RMP defines the scope and process for the assessment and treatment of risks. The objective of this plan is to define the strategy to manage risks of an organization or project with the minimal impact on cost and schedule, as well as operational performance. The RMP is considered a living document, being updated as needed. A typical RMP comprises the following steps (detailed in Table 1 ): (1) Introduction, (2) Planning, (3) Execution.
RMP and DMP Correlation
Each research project has specific purposes, resulting in specific policies and thus in different instances of DMP. However, there are always common issues allowing the definition of generic DMP guidelines, as proved from the comparative analysis at (Ferreira et al, 2013b) . From that we defined a set of typical sections to identify common risks, like ethical risks (Kaye et al, 2010) , metadata preservation risks (Day, 2004) or data dissimination risks (Bimholtz et al, 2003) . A more detailed list of typicall risks related to e-Science and its workflows is presented in (Ferreira et al, 2013a) .
IDCC14 | Research Paper

Analysis Process for RMP Creation
In order to assure we can be efficient and effective in a systematic way, a generic process for the definition of an RMP for e-Science projects should be possible. This process must be able to effectively create an RMP for an e-Science project and also to align it with a corresponding DMP.
The process we propose, in response to the previous hypothesis, is based on good practices from the ISO 31000, an RM reference. The process, as presented in Table 1 , is based on three phases, each made of a set of steps, with expected results. The method is more detailed in (Ferreira et al, 2013b) . Table 1 . Proposal of analysis process for creation of RMP.
Phase Step
Expected results The process and rate of monitoring is defined according to each control and the total duration of the project In order to validate the proposed method, we applied it to a real case, which results are detailed in the next section, and can be compared with the expected results mentioned previously.
Introduction
Process Validation: The MetaGen-FRAME Project
The MetaGen-FRAME project is presented as a case study for validation of the proposed process. It is a Metagenomics (enables the study of populations of microorganisms, namely metagenomes (Wooley et al, 2010)) project whose practical results (Ferreira et al, 2013b) are presented in the next few sections according with the process phases presented in Table 1 .
Phase One -Context
The MetaGen-FRAME is described (step 1.1) as a Metagenomics project that uses relatively-controlled environments (possibly composed by several types of different bacteria, with each type being present in different quantities), whose chemical reactions may be influenced and enhanced. The project is focused on the study of bacteria (prokaryotes). The origin of a metagenome can vary, ranging from an open environment, like the ocean, to a closed one like the human digestive system. The tools used for task execution are pre-selected. The project's main tasks are shown in Figure 2 in more detail.
The RMP goal and purpose (step 1.2) is to describe how the MetaGen-FRAME risks are identified, analysed and evaluated, and also how the RM activities are performed and monitored. This RMP also intents to complement the corresponding DMP as it was stated before.The intented audience of this RMP is the project and management team.
Regarding the Authority in the project (step 1.3), FCT (Fundação para a Ciência e a Tecnologia) was identified as the founder of the project. There is no official RM authority in the RM analysis of this project. The RMP is addressing an e-Science environment, namely in Metagenomics (step 1.4) . Figure 2 . The MetaGen-FRAME workflow (detailed in Table 9 of the appendix section).
Phase Two -Planning
In phase 2, the stakeholders involved, and their responsibilities, were identified in a responsibility assignment (RACI) chart in Table 2 ( step 2.1) . The techniques used in the stages of risk assessment were taken from the ISO 31010, which were (step 2.2): (1) for risk identification: check lists, brainstorming, SWIFT, FMEA/FMECA, HRA; (2) for risk analysis: SWIFT, FMEA/FMECA, HRA, decision tree analysis; (3) for risk evaluation: a risk matrix. 
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Phase Three -Execution (Proceedings)
For step 3.1, the following types of assets were identified in the MetaGen-FRAME project: Data (A1); Tools (A2) (e.g. Taverna, Blast2GO, NGS QC Toolkit, BG7, MetaPhlAn, TAPyR); Computational servers (A3), Databases (A4), Local personal computer (PC), (A5), Web-services (A6) and Workflow/Tasks (A7). The corresponding vulnerabilities and the events that can exploit those same vulnerabilities and affect the assets are expressed in Table 3 and Table 4 . V7 Economic or organizational breakdowns can also influence the organization running the NCBI, causing its termination V8 Lack of a criteria set, defining if a certain data set is confidential or not Regarding risk identification (step 3.2) , the MetaGen-FRAME project extrapolates several types of information from the data set it receives as input, such as the composition of the organism community present in the sample. It also aims to produce information pertaining the metabolism and main chemical reactions. With a particular focus on prokaryotic organisms, this raises important issues associated with the secrecy and storage of data, as it will potentially convey information that is important to the client or entity's activity. An example of such an activity is the process of analyzing and enhancing biomass decomposition, fuel refinement, crude extraction, among others. Such processes may constitute trade secrets, and their study must undertake the precautions mentioned earlier. The project also uses remote WS, so ensuring that the information and services available remotely will remain active is a key-necessity for biologists and other professionals. The identified risks are in Table 5 .
As the RMP intents to complement a DMP, the risks presented in Table 5 must be allocated to the generic sections of the DMP (Ferreira et al, 2013b) , leading to the distribution expressed in Table 6 . As it can be seen, all the DMP sections have at least one risk associated, showing that DMP sections can be used to categorise the risks found and there are risks associated with every DMP section considered.
To perform risk analysis (step 3.3) and calculate the level of every risk, likelihood and consequence criteria were defined according to the criterion from a very-low priority (0.1) to a very-high priority (0.9) . Risk levels are obtained by multiplying the risk's likelihood (L) and consequence (C) (L*C). The likelihood, consequence and respective risk levels of each risk are presented in Table 10 (in appendix section).
For the evaluation of risks (step 3.4) , a risk matrix was developed (see Table 8 ). From the matrix we conclude that R1 and R2 are the risks with a very-high priority, being the first ones treated. R3 and R4 have a high priority, beginning treatment after R1 and R2. The risks R5, R6, R7, R9, R10 and R11 have a medium priority, thus being the last ones treated. R8 and R12 have a low priority and need only to be controlled.
For risk treatment (step 3.5), risk control measures were identified and are presented in Table 7 . The controls use different strategies to mitigate the risk by reducing specifically the consequence of the risk, the exposure of the vulnerability, the likelihood of the event or sharing the risk with other entities. Table 5 . Identified risks, with the respective assets, vulnerabilities and events.
Risks Assets Vulnerabilities
Events R1 -Accidental change or deletion of digital objects; A1, A7 V4 E5, E10
R2 -Insertion of wrong input values: One example is the introduction of the wrong value in variables that indicate the percentage of a sequence's nucleotides that must be of quality regarding the total length of the sequences which are filtered in the data quality control task, therefore influencing all the following results; All the risks and controls for the MetaGen-FRAME project need to be monitored (step 3.6) in a monthly basis until the end of the project. For each review the risks and control's effectiveness must be communicated to all involved stakeholders.
Conclusions and Future Work
RM has applications in different areas and projects. In e-Science, collaboration and DM are crucial. New challenges and risks are raised and must be assessed so the project's data can be preserved and reused. To answer these dilemmas, DMP are developed before a research project takes place. The paper tries to give added value to the DMP concept using RM principles so that the emerging risks surrounding e-Science projects and DP can be met, becoming necessary to understand how RM can enhance DMP. In order to assess that a process that uses jointly DMP and ISO 31000 to create RMP is proposed.
Our motivation for the proposed process resides in the field of Metagenomics with the MetaGen-FRAME case study. In the case study RM analysis: (i) twelve risks were identified; (ii) all the risks were sucessfully analysed; (iii) all the risks were sucessfully evaluated with the determination of which risks need treatment or only control; (iv) risk treatment and control measures were found for each risk; (v) all the typical DMP sections were complemented by the RMP, as there were risks allocated to each section. This validation is also achieved through the compliance of several evaluation metrics (Ferreira et al 2013a) . In future work, we intend to use these results to generalize the process for the development of an DM and an RMP in Bioengineering, leading to a better curation in the same domain.
